These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12689738)

  • 1. Stratified experiments reexamined with emphasis on multicenter trials.
    Ganju J; Mehrotra DV
    Control Clin Trials; 2003 Apr; 24(2):167-81. PubMed ID: 12689738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Many multicenter trials had few events per center, requiring analysis via random-effects models or GEEs.
    Kahan BC; Harhay MO
    J Clin Epidemiol; 2015 Dec; 68(12):1504-11. PubMed ID: 25985892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of rank-based procedures for multicenter clinical trials.
    Rashid MM; McKean JW; Kloke JD
    J Biopharm Stat; 2013; 23(6):1207-27. PubMed ID: 24138428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analysis of continuous outcomes in multi-centre trials with small centre sizes.
    Pickering RM; Weatherall M
    Stat Med; 2007 Dec; 26(30):5445-56. PubMed ID: 17924360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size calculation for multicenter randomized trial: taking the center effect into account.
    Vierron E; Giraudeau B
    Contemp Clin Trials; 2007 Jul; 28(4):451-8. PubMed ID: 17188941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefit of stratification in clinical trials revisited.
    Ganju J; Zhou K
    Stat Med; 2011 Oct; 30(24):2881-9. PubMed ID: 21905064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Center-weighting issues in multicenter clinical trials.
    Gallo PP
    J Biopharm Stat; 2000 May; 10(2):145-63. PubMed ID: 10803722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hazard ratio inference in stratified clinical trials with time-to-event endpoints and limited sample size.
    Xu R; Mehrotra DV; Shaw PA
    Pharm Stat; 2019 May; 18(3):366-376. PubMed ID: 30706642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative efficiency of unequal versus equal cluster sizes in cluster randomized and multicentre trials.
    van Breukelen GJ; Candel MJ; Berger MP
    Stat Med; 2007 Jun; 26(13):2589-603. PubMed ID: 17094074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of selection bias on test decisions in randomized clinical trials.
    Kennes LN; Cramer E; Hilgers RD; Heussen N
    Stat Med; 2011 Sep; 30(21):2573-81. PubMed ID: 21717489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic balanced randomization for clinical trials.
    Signorini DF; Leung O; Simes RJ; Beller E; Gebski VJ; Callaghan T
    Stat Med; 1993 Dec; 12(24):2343-50. PubMed ID: 8134737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials.
    Wang SJ; O'Neill RT; Hung HJ
    Clin Trials; 2010 Oct; 7(5):525-36. PubMed ID: 20595242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating risk difference in multicenter studies under baseline-risk heterogeneity.
    Böhning D; Sarol J
    Biometrics; 2000 Mar; 56(1):304-8. PubMed ID: 10783812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of simulation to compare the performance of minimization with stratified blocked randomization.
    Toorawa R; Adena M; Donovan M; Jones S; Conlon J
    Pharm Stat; 2009; 8(4):264-78. PubMed ID: 18756580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size allocation to regions in a multiregional trial.
    Uesaka H
    J Biopharm Stat; 2009 Jul; 19(4):580-94. PubMed ID: 20183427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical trial: myths around elementary statistical principles.
    Edler L; Kopp-Schneider A
    Onkologie; 2003 Dec; 26(6):551-6. PubMed ID: 14709929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple test of the homogeneity of risk difference in sparse data: an application to a multicenter study.
    Lui KJ
    Biom J; 2005 Oct; 47(5):654-61. PubMed ID: 16385906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials.
    Quan H; Li M; Shih WJ; Ouyang SP; Chen J; Zhang J; Zhao PL
    Stat Med; 2013 May; 32(10):1691-706. PubMed ID: 22855311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of two methods of estimating a common risk difference in a stratified analysis of a multicenter clinical trial.
    O'Gorman TW; Woolson RF; Jones MP
    Control Clin Trials; 1994 Apr; 15(2):135-53. PubMed ID: 8205804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.